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Whole-genome sequencing unveiled host and environment-
related insights to Shigella sonnei transmission within cyclic 
epidemics during 2000–2012 in Israel. The Israeli reservoir 
contains isolates belonging to S. sonnei lineage III but of 
different origin, shows loss of tetracycline resistance genes, 
and little genetic variation within the O antigen: highly rel-
evant for Shigella vaccine development.
Shigellosis is common all over the world and is hyper-endemic to developing countries where children with 
the disease have an increased risk for persistent diarrhea, 
arrested growth, and death (1–3). The annual incident cases 
of shigellosis are estimated at ≈190 million in develop-
ing countries, where Shigella flexneri is the most common 
cause of shigellosis, and ≈1 million in industrialized coun-
tries, where S. sonnei predominates (4–7).
The Study
Despite the improved socioeconomic conditions, Israel has 
remained an area where shigellosis is highly endemic, re-
porting an annual incidence rate of culture-proven shigel-
losis of ≈97 cases per 100,000 population. Cyclic outbreaks 
during 2000–2012 occur every 2 years; S. sonnei is the 
pathogen for >85% of the cases. It has been shown that the 
ultraorthodox Jewish communities, which are overcrowded 
and have a high number of children <5 years of age, were 
the epicenter of these epidemics during the past 15 years 
(5). We used whole-genome sequencing (WGS) to provide 
a high-resolution view to better understand the local micro-
evolution and patterns of S. sonnei transmission within the 
cyclic outbreaks in Israel.
A total of 281 S. sonnei isolates were subject to WGS 
(Figure 1; online Technical Appendix Table 1, https://ww-
wnc.cdc.gov/EID/article/24/7/17-1313-Techapp1.pdf). 
We collected data from isolates during the epidemic years 
2000, 2002, 2004, 2006, 2008, and 2012, and the nonepi-
demic years 2001 and 2003. All isolates were from children 
of various sanitary, socioeconomic, cultural, and ethnic 
backgrounds: ultraorthodox Jews, secular Jews, and Israeli 
Arabs. The ultraorthodox Jews represent ≈11% of the total 
population of Israel. This population group resides in towns 
or neighborhoods separated from the secular Jewish popu-
lation (8) and also in mixed ones. The Israeli Arabs, who 
are estimated to account for 20% of the total population, 
reside mostly in rural areas and in towns or neighborhoods 
separated from the Jewish population; but they also live in 
towns inhabited by both Jews and Arabs (8). Of the 281 
isolates, 263 (93.5%) were collected from Jewish children 
(mainly from ultraorthodox communities) and 18 (6.4%) 
isolates were from Israeli Arab children (mainly Bedouins 
living in southern Israel).
The WGS analysis showed that the clones within 
the Israeli reservoir formed 2 distinct subclades: a major 
subclade (subclade I) containing ≈94% of the Israeli col-
lection, which is more prevalent among Jewish children 
(92% originated from Jewish children); and a minor sub-
clade (subclade II) containing ≈5.7% of the Israeli collec-
tion, which is more prevalent among Israeli Arab children 
(82%). Only 1 isolate (≈0.3%) did not cluster with any of 
the Israeli isolates (Figure 1).
A comparison to global analyses (9) suggests that 
even though both subclades belong to S. sonnei lineage 
III, they are of different origins. Subclade II clones were 
more closely related to isolates that originated in Egypt 
and Iran than to the Israeli subclade I clones that seem 
to be endemic and have a distinctive recombination site, 
as previously described for 1 sequenced isolate from a 
patient in Israel in 2003 (9; online Technical Appendix 
Table 2). They were also found to distinguish S. sonnei 
among Jewish Orthodox communities of various coun-
tries (10). Nine of 13 Israeli Arab strains in clade II were 
isolated from Bedouins living in the vicinity of the Egyp-
tian border. The frequent migration over the Israel–Egypt 
border of Bedouins often belonging to the same tribe 
Microevolution and Patterns of  
Transmission of Shigella sonnei within  
Cyclic Outbreaks of Shigellosis, Israel
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 24, No. 7, July 2018 1335
Author affiliations: Tel Aviv University, Tel Aviv, Israel (A. Behar,  
D. Cohen); Kimron Veterinary Institute, Beit Dagan, Israel  
(A. Behar); The Wellcome Trust Sanger Institute, Hinxton,  
Cambridge, UK (K.S. Baker, N.R. Thomson); University of  
Liverpool, Liverpool, UK (K.S. Baker); Israel Center for Disease 
Control, Jerusalem, Israel (R. Bassal); Central Laboratories,  
Ministry of Health, Jerusalem (A. Ezernitchi, L. Valinsky)
DOI: https://doi.org/10.3201/eid2407.171313
DISPATCHES
1336 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 24, No. 7, July 2018
Figure 1. Whole-genome sequencing and phylogenetic 
analysis of 281 Shigella sonnei isolated in Israel, 2000–2012. 
Scale bar indicates nucleotide polymorphisms.
Transmission of Shigella sonnei, Israel
could explain the possible importation of subclade II S. 
sonnei from Egypt and/or through Egypt, similar to the 
recent transborder silent spread of poliovirus type 1, an-
other fecal–orally transmitted enteropathogen in south-
ern Israel (11). Our results also indicate that in general, 
isolates from Israeli Arab children who reside in mixed 
settlements and in close proximity to Jewish children 
commonly have positive test results for Shigella strains 
in clade 1. Only 5 (1.9%) isolates in clade I originated 
from Israeli Arabs (Figure 1). Of note, 4 of the 5 isolates 
were obtained from samples from Arab children residing 
in Beer Sheva (3 isolates) and Mevaseret Zion (1 isolate), 
cities inhabited by both Jews and Arabs. Consequently, 
it appears that a combination of both biogeography and 
ethnicity forming microhabitats for S. sonnei clone cir-
culation shapes the differences observed between Jewish 
and Israeli Arab children.
Each subclade could be further subdivided into clonal 
groups consisting of clusters of isolates with <30 chro-
mosomal single-nucleotide polymorphism (SNP) differ-
ences from the nearest neighboring cluster. We defined a 
total of 20 unique and distinct S. sonnei endemic clones 
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Figure 2. The relative 
distribution of the various whole-
genome sequencing defined 
Shigella sonnei clones per year 
of isolation, 2000–2012.
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circulating in the Israeli population (Figure 2, panels 
A–U). The majority of the clones (≈69%; Figure 2) can 
be found throughout the years regardless of the shigello-
sis outbreaks that occurred in Israel every 2 years during 
2000–2012, suggesting some mechanism of persistence 
(5). Contrary to our hypothesis, neither the establishment 
and dynamics of persistent or dominant clones could ex-
plain the Israeli cyclic outbreaks. Moreover, we found no 
specific genetic attributes that could distinguish them from 
other clones. Therefore, we postulate that the cyclic peaks 
of morbidity rates associated with S. sonnei are the result 
of changes in the level of natural immunity, as was shown 
by several observational studies (5,12,13). An outbreak 
of shigellosis occurring among children 0–4 years of age 
will lead to an increase in the level of natural immunity 
to the homologous Shigella organism (S. sonnei), which 
will also provide the level of herd immunity sufficient to 
prevent the onset of a new epidemic. After 1 or 2 years, 
declining levels of antibodies, together with the intake of 
a new cohort of naive newborns, will lead to a decrease in 
the level of herd immunity below a critical level. High and 
continuous exposure to a variety of circulating S. sonnei 
clones in children 0–4 years of age who live in crowded 
conditions will lead to the renewal of the epidemic trans-
mission of these clones (5).
Conclusions
Although we excluded all S. sonnei plasmids from the phy-
logenetic analysis, plasmid reads were mapped and the as-
sembled sequences compared with the reference plasmid 
sequences. Our data suggest that plasmid spA is undergo-
ing degradation as a result of the loss of tetracycline resis-
tance genes over time. This finding is consistent with the 
results of Holt et al. for the Middle East (III) clade (9) and 
with laboratory examination showing that the S. sonnei Is-
raeli reservoir is becoming less resistant to tetracycline (5) 
(p-value for linear trend <0.01) (online Technical Appen-
dix Table 3).
Although notoriously unstable when S. sonnei is 
grown on laboratory media, invasive plasmid pINVB 
was present in ≈58% of our isolate sequences. Our re-
sults demonstrate that S. sonnei O antigen encoded on 
this plasmid is well-conserved within the S. sonnei Israe-
li reservoir. No SNPs were detected in genes that belong 
to the O antigen gene cluster in ≈97% of the plasmids, 
and pINVB seems to be under very little immune se-
lection as has been also shown in other studies (9,14). 
We identified a single SNP leading to a nonsynonymous 
substitution, in gene wbgW within the O antigen gene 
cluster that was shared by only 4 (2.4%) isolate plas-
mids. We also identified in 1 (≈0.6%) isolate 1 SNP, a 
nonsynonymous change in gene wbgY. To date, Shigella 
vaccine development has mainly focused on serotype-
targeted vaccines that are based on shigella O antigen 
(15). Thus, our findings may have implications for pub-
lic health as the need for a safe and effective Shigella 
vaccine becomes more pressing (15).
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